(Q38850577)

7 September 2017

title

Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis (English)

1 reference

7 September 2017

Laëtitia Basset

1

1 reference

7 September 2017

Sylvie Chevalier

2

1 reference

7 September 2017

Yannic Danger

3

1 reference

7 September 2017

Muhammad Imran Arshad

4

1 reference

7 September 2017

Claire Piquet-Pellorce

5

1 reference

7 September 2017

Hugues Gascan

6

1 reference

7 September 2017

Michel Samson

7

1 reference

7 September 2017

publication date

23 July 2015

1 reference

Journal of Molecular Medicine

7 September 2017

published in

1 reference

7 September 2017

volume

93

1 reference

7 September 2017

issue

12

1 reference

7 September 2017

page(s)

1355-1367

1 reference

Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Expression of IL-27 in human Th1-associated granulomatous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Cloning and characterization of a novel class I cytokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Development of Th1-type immune responses requires the type I cytokine receptor TCCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Protection and pathology during parasite infection: IL-10 strikes the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Potent antitumor activity of interleukin-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Cutting edge: a key pathogenic role of IL-27 in T cell- mediated hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Critical contribution of liver natural killer T cells to a murine model of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

ADAM12 in human liver cancers: TGF-β-regulated expression in stellate cells is associated with matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-27: balancing protective and pathological immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-γ dysregulation of CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-015-1319-6

Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system

21 January 2018

1 reference

12 December 2020

A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes

1 reference

12 December 2020

TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis

1 reference

12 December 2020

Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A

1 reference

12 December 2020

Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation

1 reference

12 December 2020

WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection

1 reference

12 December 2020

10.1007/S00109-015-1319-6

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1023505865

0 references

1 reference